RGTA

RGTA (ReGeneraTing Agent) refers to a class of chemically substituted polysaccharides designed to mimic and replace degraded heparan sulfate (HS) in injured tissues. These hemisynthetic polymers are typically based on dextran backbones and are engineered with sulfates, carboxyl groups, and sometimes other functional groups for optimal interaction with extracellular matrix proteins and growth factors. The primary mechanism of action is the protection and potentiation of signaling peptides and growth factors—such as FGF, VEGF, TGFβ—by binding them, shielding them from proteolytic degradation, controlling their bioavailability, enhancing their receptor affinity, and reestablishing extracellular matrix communication networks. This results in improved tissue healing through enhanced cell migration/differentiation, angiogenesis promotion, protection against oxidative stress/apoptosis, and restoration of normal wound healing processes. RGTAs have been studied extensively in preclinical models for various pathological contexts involving tissue injury[1].

Brand names

RGTA

Other names

ReGeneraTing Agentheparan sulfate mimeticRGTA®